IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,188 | -35.4% | 1,360,000 | 0.0% | 0.08% | -31.5% |
Q2 2023 | $9,574 | +15.2% | 1,360,000 | 0.0% | 0.12% | +8.8% |
Q1 2023 | $8,310 | -4.4% | 1,360,000 | 0.0% | 0.11% | -0.9% |
Q4 2022 | $8,690 | -99.9% | 1,360,000 | +17.2% | 0.12% | -24.8% |
Q3 2022 | $11,113,000 | -13.2% | 1,160,000 | 0.0% | 0.15% | -5.0% |
Q2 2022 | $12,806,000 | +494.0% | 1,160,000 | +411.7% | 0.16% | +496.3% |
Q1 2019 | $2,156,000 | +7.5% | 226,681 | 0.0% | 0.03% | -6.9% |
Q4 2018 | $2,006,000 | -55.5% | 226,681 | -43.4% | 0.03% | -50.0% |
Q3 2018 | $4,507,000 | -8.7% | 400,603 | +3.9% | 0.06% | -14.7% |
Q2 2018 | $4,934,000 | – | 385,446 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |